Table 3 Outcomes at 24, 48 weeks post-ART initiation
| Â | Total (384) | TB-IRIS (72) | Non TB-IRIS (312) | P |
|---|---|---|---|---|
HIV response | Â | Â | Â | Â |
 HIV VL < 50 copies/mL at week 24, n (%) | 248(248/332, 74.7%) | 48(48/62, 77.4%) | 200(200/270, 74.1%) | 0.585 |
 HIV Vl < 50 copies/mL at week 48, n (%) | 281(281/331, 84.9%) | 53(53/63, 84.1%) | 228(228/268, 85.1%) | 0.850 |
 Increase of CD4+T-cell counts (cells/µL) at week 24*, median [IQR] | 81(36, 122) | 97(55, 130) | 62(25, 117) | 0.005 |
 Increase of CD4+T-cell counts (cells/µL) at week 48*, median [IQR] | 101(49, 170) | 132(79, 201) | 65(28, 115) | 0.015 |